Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Health Indicator Report of Prostate Cancer Deaths

Prostate cancer is the second most commonly occurring form of cancer for men, and is the second leading cause of cancer death for men in both Utah and the U.S.

Prostate Cancer Deaths per 100,000 Men by Race, Utah, 2014-2018

Notes

ICD-10 codes used to define prostate cancer: C61.   [[br]] Age-adjusted to U.S. 2000 standard population using 3 age groups, 0-44, 45-64, and 65+. [[br]] *Use caution when interpreting rate; the estimates do not meet UDOH standards for reliability.[[br]]

Data Sources

  • Utah Death Certificate Database, Office of Vital Records and Statistics, Utah Department of Health
  • Population Estimates by Age, Sex, Race, and Hispanic Origin for Counties in Utah, U.S. Bureau of the Census, IBIS Version 2018

Definition

The rate of death from cancer of the prostate (ICD-10: C61) per 100,000 men.

Numerator

The number of deaths due to prostate cancer for a given year (ICD-10: C61).

Denominator

The male population in Utah or the U.S. for a given year.

Healthy People Objective C-7:

Reduce the prostate cancer death rate
U.S. Target: 21.8 deaths per 100,000 males

Other Objectives

CSTE Chronic Disease Indicators

How Are We Doing?

In 2018, the Utah age-adjusted prostate cancer mortality rate was 22.1 deaths per 100,000 males. There was no significant difference in prostate cancer mortality across geography (at the local health district level; see additional data views for additional differences between Utah Small Areas) from 2014-2018, nor was there a significant difference across ethnic groups from 2016-2018. From 2014-2018, men who racially identified as Asian had a significantly lower rate of prostate cancer mortality (3.7 deaths per 100,000 males) compared to other races, though caution should be used in interpreting these rates as these estimates have a high coefficient of variation.

How Do We Compare With the U.S.?

The U.S. prostate cancer age-adjusted mortality rate has generally been decreasing over time, from 24.2 deaths per 100,000 males in 2007 to 18.7 deaths per 100,000 males in 2017. The Utah age-adjusted prostate cancer mortality rate trend has been more variable from year-to-year, though rates have generally been near the national rate. In 2017, the Utah age-adjusted prostate cancer mortality rate was 19.7 deaths per 100,000 males while the national rate was 18.7 deaths per 100,000 males.

What Is Being Done?

The Utah Department of Health initiated the Utah Cancer Action Network (UCAN), a statewide partnership whose goal is to reduce the burden of cancer. The mission of the UCAN is to lower cancer incidence and mortality in Utah through collaborative efforts directed toward cancer prevention and control. As a result of this planning process, objectives and strategies have been developed by community partners regarding the early detection of cervical, breast, and colorectal cancers as well as the promotion of physical activity, healthy eating habits, melanoma cancer prevention, and cancer survivorship advocacy.

Evidence-based Practices

Screening recommendations have changed over time. Until recently, many doctors and professional organizations encouraged yearly PSA screening for men beginning at age 50. However, as more has been learned about both the benefits and harms of prostate cancer screening, a number of organizations have begun to caution against routine population screening. Although some organizations continue to recommend PSA screening, there is widespread agreement that any man who is considering getting tested should first be informed in detail about the potential harms and benefits. Since 2012 the U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer. Healthy diet, exercise, and lifestyle play an important role in cancer prevention.

Available Services

Currently, Medicare provides coverage for an annual PSA test for all Medicare-eligible men age 50 and older. Many private insurers cover regular PSA screening tests as well. Check with your insurance provider and doctor's office to discuss when prostate cancer screening may be right for you.
Page Content Updated On 10/28/2019, Published on 10/30/2019
The information provided above is from the Department of Health's Center for Health Data IBIS-PH web site (http://ibis.health.state.gov). The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Fri, 06 December 2019 0:40:25 from Department of Health, Center for Health Data, Indicator-Based Information System for Public Health Web site: http://ibis.health.state.gov ".

Content updated: Wed, 30 Oct 2019 09:22:15 MDT